Company news
Vir Biotechnology, Inc. (NASDAQ:VIR) news
Every Vir Biotechnology, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Vir Biotechnology to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
August 31, 2026
Vireo Growth Receives Regulatory Approval and Completes Acquisition of PharmaCann Colorado Retail Assets
August 7, 2026
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2026 Financial Results
August 5, 2026
Vir Biotechnology Announces Chief Financial Officer Transition
July 24, 2026
Vir Biotechnology to Host Conference Call for Second Quarter 2026 Financial Results
July 22, 2026
Vir Biotechnology Announces Appointment of Timothy Coughlin to its Board of Directors
June 10, 2026
Vir Biotechnology to Present Complete Week 96 Data from Phase 2 SOLSTICE Clinical Trial in Hepatitis Delta at the European Association fo...
May 18, 2026
Sotrovimab (Xevudy: Vir Biotechnology, GlaxoSmithKline) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecast...
May 11, 2026
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 6, 2026
Vir Biotechnology to Participate in Bank of America Securities 2026 Healthcare Conference
May 5, 2026
Vir Biotechnology to Host Conference Call for First Quarter 2026 Financial Results
April 23, 2026
Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer
April 16, 2026
Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell ...
April 13, 2026
Vir Biotechnology to Participate in Upcoming Investor Conferences
February 26, 2026
Vir Biotechnology Announces Pricing of Public Offering of Common Stock
February 25, 2026
Vir Biotechnology Announces Proposed Public Offering of Common Stock
February 24, 2026
Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients ...
February 23, 2026
Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR...
February 23, 2026
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
February 23, 2026
Vir Biotechnology to Host Conference Call for Fourth Quarter and Full Year 2025 Financial Results
February 9, 2026
Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones
January 12, 2026
Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology
December 17, 2025
Vir Biotechnology Grants Norgine Exclusive Commercial License to Chronic Hepatitis Delta Treatment Candidate in Europe, Australia & New Z...
December 16, 2025
Vir Biotechnology to Participate in the 8th Annual Evercore Healthcare Conference
November 19, 2025
Vir Biotechnology Announces AASLD The Liver Meeting® Presentation & New England Journal of Medicine Publication of Phase 2 Data Demonstra...
November 9, 2025
Vir Biotechnology to Participate in the Jefferies 2025 London Healthcare Conference
November 7, 2025
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2025 Financial Results
November 5, 2025
Vir Biotechnology Announces Completion of Enrollment in ECLIPSE 1 Phase 3 Trial for Chronic Hepatitis Delta
November 3, 2025
Vir Biotechnology to Provide Corporate Update and Report Third Quarter 2025 Financial Results on November 5, 2025
October 22, 2025
Vir Biotechnology Announces First Patient Dosed in Part 3 of Phase 1 Trial of PSMA-Targeting PRO-XTEN® Dual-Masked T-Cell Engager VIR-550...
October 9, 2025
Vir Biotechnology to Present Week 48 SOLSTICE Clinical Results in Hepatitis Delta at AASLD’s The Liver Meeting® 2025
October 7, 2025
Vir Biotechnology to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
August 25, 2025
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2025 Financial Results
August 6, 2025
Vir Biotechnology Successfully Initiates all Trials in ECLIPSE Registrational Program for Chronic Hepatitis Delta
August 6, 2025
Vir Biotechnology Initiates Second Pivotal Trial in Its Global ECLIPSE Registrational Program for Chronic Hepatitis Delta
July 31, 2025
Vir Biotechnology Announces First Patient Dosed in Phase 1 Clinical Trial of EGFR-Targeting PRO-XTEN™ Dual-Masked T-Cell Engager VIR-5525...
July 24, 2025
Vir Biotechnology to Provide Corporate Update and Report Second Quarter 2025 Financial Results on August 6, 2025
July 22, 2025
Invenra Welcomes Dr. Alan J. Korman to Its Scientific Advisory Board
July 14, 2025
Vir Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025
May 28, 2025
Vir Biotechnology to Participate in TD Cowen 6th Annual Oncology Innovation Summit
May 20, 2025
Vir Biotechnology to Participate in Bank of America Securities 2025 Healthcare Conference
May 12, 2025
Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis...
May 9, 2025
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2025 Financial Results
May 7, 2025
Vir Biotechnology to Provide Corporate Update and Report First Quarter 2025 Financial Results on May 7, 2025
April 30, 2025
Vir Biotechnology to Present Latest Clinical Data in Hepatitis Delta and B Programs at the European Association for the Study of the Live...
April 24, 2025
Brii Biosciences Provides Corporate Update and Reports Full-Year 2024 Financial Results
March 21, 2025
Vir Biotechnology Enrolls First Patient in Phase 3 ECLIPSE Registrational Program for Chronic Hepatitis Delta
March 13, 2025
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
February 26, 2025
Vir Biotechnology to Participate in TD Cowen 45th Annual Health Care Conference
February 19, 2025